BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 24921459)

  • 1. Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation.
    Guo Y; Tian Y; Wang H; Si Q; Wang Y; Lip GYH
    Chest; 2015 Jan; 147(1):109-119. PubMed ID: 24921459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.
    Guo Y; Wang H; Tian Y; Wang Y; Lip GYH
    Chest; 2015 Jul; 148(1):62-72. PubMed ID: 25501045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of first-ever stroke in younger patients with atrial fibrillation not recommended for antithrombotic therapy by current guidelines: a population-based study in an East Asian cohort of 22 million people.
    Chang KC; Wang YC; Ko PY; Wu HP; Chen YW; Muo CH; Sung FC; Li TC; Hsu CY
    Mayo Clin Proc; 2014 Nov; 89(11):1487-97. PubMed ID: 25444485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study.
    Fauchier L; Clementy N; Pelade C; Collignon C; Nicolle E; Lip GY
    Stroke; 2015 Sep; 46(9):2432-7. PubMed ID: 26251249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA
    Lee SR; Choi EK; Han KD; Cha MJ; Oh S
    Int J Cardiol; 2017 Jun; 236():226-231. PubMed ID: 28233629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.
    Saliba W; Rennert G
    Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation.
    Ntaios G; Lip GY; Lambrou D; Papavasileiou V; Manios E; Milionis H; Spengos K; Makaritsis K; Vemmos K
    Neurology; 2015 Mar; 84(12):1213-9. PubMed ID: 25695964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of the CHADS2 and CHA2DS2-VASc scores in post-myocardial infarction patients: Risk of new occurrence of atrial fibrillation and ischemic stroke.
    Lau KK; Chan PH; Yiu KH; Chan YH; Liu S; Chan KH; Yeung CY; Li SW; Tse HF; Siu CW
    Cardiol J; 2014; 21(5):474-83. PubMed ID: 24846512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Lip GY; Chen SA
    Heart Rhythm; 2014 Oct; 11(10):1752-9. PubMed ID: 24952148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
    Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk and prediction of dementia in patients with atrial fibrillation--a nationwide population-based cohort study.
    Liao JN; Chao TF; Liu CJ; Wang KL; Chen SJ; Tuan TC; Lin YJ; Chang SL; Lo LW; Hu YF; Chung FP; Tsao HM; Chen TJ; Lip GY; Chen SA
    Int J Cardiol; 2015 Nov; 199():25-30. PubMed ID: 26173170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple risk factors and ischaemic stroke in the elderly Asian population with and without atrial fibrillation. An analysis of 425,600 Chinese individuals without prior stroke.
    Guo Y; Wang H; Tian Y; Wang Y; Lip GY
    Thromb Haemost; 2016 Jan; 115(1):184-92. PubMed ID: 26322338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation, CHA2DS2-VASc score, antithrombotics and risk of non-traffic-, non-cancer-related bone fractures: A population-based cohort study.
    Lai HC; Chien WC; Chung CH; Lee WL; Wu TJ; Wang KY; Liu CN; Liu TJ
    Eur J Intern Med; 2015 Dec; 26(10):798-806. PubMed ID: 26493861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
    J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHADS2 and CHA2DS2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation/atrial flutter patients.
    Naccarelli GV; Panaccio MP; Cummins G; Tu N
    Am J Cardiol; 2012 May; 109(10):1526-33. PubMed ID: 22360819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Prostran MS; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):319-26. PubMed ID: 22319004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.